News
Helena Yu, MD, discusses the efficacy of zipalertinib for EGFR-mutant non–small cell lung cancer and the importance of ...
Angiotensin receptor neprilysin inhibitors (ARNi), beyond blocking angiotensin II signaling, augment natriuretic peptides ... Glomerular filtration rate (GFR), proteinuria, serum, and urinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback